PRO DEX INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on November 20, 2025, for PRO DEX INC (PDEX), a company incorporated in Colorado with principal executive offices in Irvine, California. The filing details the results of the 2025 Annual Meeting of Shareholders and specific executive compensation actions approved by the Compensation Committee.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figures disclosed relate to executive compensation:
- CEO Cash Bonus: Richard L. Van Kirk (CEO) was awarded a discretionary cash bonus of $30,830, calculated based on the value of 1,000 shares of common stock at the closing price on November 20, 2025. Payment is scheduled for November 26, 2025.
- Restricted Stock Grants: 1,000 restricted shares were granted to Alisha K. Charlton (CFO), vesting ratably over five years. Similar grants were made to non-employee directors and select employees.
Material Changes and Corporate Actions
The filing reports the following material corporate actions and shareholder votes:
- Board Elections: Shareholders elected seven directors to the Board of Directors: Raymond E. Cabillot, Angelita R. Domingo, William J. Farrell III, David C. Hovda, Katrina M.K. Philp, Nicholas J. Swenson, and Richard L. Van Kirk. All candidates received majority support.
- Auditor Ratification: Shareholders ratified the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
- Equity Plan Extension: Shareholders approved an amendment to the 2016 Equity Incentive Compensation Plan to extend its term for an additional ten years.
- Compensation Advisory Votes: Shareholders approved the compensation of Named Executive Officers (Say-on-Pay) and voted for a one-year frequency for future advisory votes on executive compensation.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future outlook, or specific risk factors beyond standard disclosures regarding the terms of the equity awards (e.g., continued employment requirements for vesting). The filing notes that the description of Award Agreements is qualified by reference to the complete text of the agreements filed as Exhibit 10.1.
Key Facts for Investor Verification
- Verify the total number of shares outstanding and the impact of the 1,000 restricted shares granted to the CFO and other employees on future dilution.
- Review the definitive proxy statement filed on October 7, 2025, for detailed biographies of the newly elected directors and the specific terms of the extended Equity Incentive Plan.
- Confirm the closing stock price on November 20, 2025, to validate the $30,830 CEO bonus calculation.
- Monitor the upcoming fiscal year-end (June 30, 2026) financial reports prepared by the newly ratified auditor, Baker Tilly US, LLP.